{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:12:15Z","timestamp":1774037535620,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,9,29]],"date-time":"2010-09-29T00:00:00Z","timestamp":1285718400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1471-2407-10-517","type":"journal-article","created":{"date-parts":[[2010,9,29]],"date-time":"2010-09-29T18:14:26Z","timestamp":1285784066000},"source":"Crossref","is-referenced-by-count":33,"title":["Epigenetic regulation of CD44in Hodgkin and non-Hodgkin lymphoma"],"prefix":"10.1186","volume":"10","author":[{"given":"Sonja","family":"Eberth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena M","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Romani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarete","family":"Zaborski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiner","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans G","family":"Drexler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilmar","family":"Quentmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,29]]},"reference":[{"key":"2316_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA: The hallmarks of cancer. Cell. 2000, 100: 57-70. 10.1016\/S0092-8674(00)81683-9.","journal-title":"Cell"},{"key":"2316_CR2","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1056\/NEJMra023075","volume":"349","author":"JG Herman","year":"2003","unstructured":"Herman JG, Baylin SB: Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med. 2003, 349: 2042-2054. 10.1056\/NEJMra023075.","journal-title":"N Engl J Med"},{"key":"2316_CR3","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJMra072067","volume":"358","author":"M Esteller","year":"2008","unstructured":"Esteller M: Epigenetics in cancer. N Engl J Med. 2008, 358: 1148-1159. 10.1056\/NEJMra072067.","journal-title":"N Engl J Med"},{"key":"2316_CR4","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev.biochem.74.010904.153721","volume":"74","author":"MG Goll","year":"2005","unstructured":"Goll MG, Bestor TH: Eukaryotic cytosine methyltransferases. Annu Rev Biochem. 2005, 74: 481-514. 10.1146\/annurev.biochem.74.010904.153721.","journal-title":"Annu Rev Biochem"},{"key":"2316_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1101\/gad.947102","volume":"16","author":"A Bird","year":"2002","unstructured":"Bird A: DNA methylation patterns and epigenetic memory. Genes Dev. 2002, 16: 6-21. 10.1101\/gad.947102.","journal-title":"Genes Dev"},{"key":"2316_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1586\/era.09.164","volume":"10","author":"FP Santos","year":"2010","unstructured":"Santos FP, Kantarjian H, Garcia-Manero G, Issa JP, Ravandi F: Decitabine in the treatment of myelodysplastic syndromes. Expert Rev Anticancer Ther. 2010, 10: 9-22. 10.1586\/era.09.164.","journal-title":"Expert Rev Anticancer Ther"},{"key":"2316_CR7","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/72785","volume":"24","author":"JF Costello","year":"2000","unstructured":"Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomaki P, Lang JC, et al: Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet. 2000, 24: 132-138. 10.1038\/72785.","journal-title":"Nat Genet"},{"key":"2316_CR8","first-page":"3225","volume":"61","author":"M Esteller","year":"2001","unstructured":"Esteller M, Corn PG, Baylin SB, Herman JG: A gene hypermethylation profile of human cancer. Cancer Res. 2001, 61: 3225-3229.","journal-title":"Cancer Res"},{"key":"2316_CR9","first-page":"1114","volume":"63","author":"MF Paz","year":"2003","unstructured":"Paz MF, Fraga MF, Avila S, Guo M, Pollan M, Herman JG, Esteller M: A systematic profile of DNA methylation in human cancer cell lines. Cancer Res. 2003, 63: 1114-1121.","journal-title":"Cancer Res"},{"key":"2316_CR10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1476-4598-8-86","volume":"8","author":"S Rohrs","year":"2009","unstructured":"Rohrs S, Dirks WG, Meyer C, Marschalek R, Scherr M, Slany R, Wallace A, Drexler HG, Quentmeier H: Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in acute myeloid leukemia. Mol Cancer. 2009, 8: 86-10.1186\/1476-4598-8-86.","journal-title":"Mol Cancer"},{"key":"2316_CR11","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/leu.2009.5","volume":"23","author":"S Rohrs","year":"2009","unstructured":"Rohrs S, Romani J, Zaborski M, Drexler HG, Quentmeier H: Hypermethylation of Death-Associated Protein Kinase 1 differentiates natural killer cell lines from cell lines derived from T-acute lymphoblastic leukemia. Leukemia. 2009, 23: 1174-1176. 10.1038\/leu.2009.5.","journal-title":"Leukemia"},{"key":"2316_CR12","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1038\/sj.leu.2404345","volume":"20","author":"FB Rahmatpanah","year":"2006","unstructured":"Rahmatpanah FB, Carstens S, Guo J, Sjahputera O, Taylor KH, Duff D, Shi H, Davis JW, Hooshmand SI, Chitma-Matsiga R, et al: Differential DNA methylation patterns of small B-cell lymphoma subclasses with different clinical behavior. Leukemia. 2006, 20: 1855-1862. 10.1038\/sj.leu.2404345.","journal-title":"Leukemia"},{"key":"2316_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/carcin\/bgl092","volume":"28","author":"H Shi","year":"2007","unstructured":"Shi H, Guo J, Duff DJ, Rahmatpanah F, Chitima-Matsiga R, Al-Kuhlani M, Taylor KH, Sjahputera O, Andreski M, Wooldridge JE, et al: Discovery of novel epigenetic markers in non-Hodgkin's lymphoma. Carcinogenesis. 2007, 28: 60-70. 10.1093\/carcin\/bgl092.","journal-title":"Carcinogenesis"},{"key":"2316_CR14","doi-asserted-by":"publisher","first-page":"8511","DOI":"10.1158\/0008-5472.CAN-07-1016","volume":"67","author":"KH Taylor","year":"2007","unstructured":"Taylor KH, Kramer RS, Davis JW, Guo J, Duff DJ, Xu D, Caldwell CW, Shi H: Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing. Cancer Res. 2007, 67: 8511-8518. 10.1158\/0008-5472.CAN-07-1016.","journal-title":"Cancer Res"},{"key":"2316_CR15","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1182\/blood-2008-04-152900","volume":"113","author":"JI Martin-Subero","year":"2009","unstructured":"Martin-Subero JI, Kreuz M, Bibikova M, Bentink S, Ammerpohl O, Wickham-Garcia E, Rosolowski M, Richter J, Lopez-Serra L, Ballestar E, et al: New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood. 2009, 113: 2488-2497. 10.1182\/blood-2008-04-152900.","journal-title":"Blood"},{"key":"2316_CR16","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1182\/blood-2003-07-2356","volume":"103","author":"A Sanchez-Aguilera","year":"2004","unstructured":"Sanchez-Aguilera A, Delgado J, Camacho FI, Sanchez-Beato M, Sanchez L, Montalban C, Fresno MF, Martin C, Piris MA, Garcia JF: Silencing of the p18INK4c gene by promoter hypermethylation in Reed-Sternberg cells in Hodgkin lymphomas. Blood. 2004, 103: 2351-2357. 10.1182\/blood-2003-07-2356.","journal-title":"Blood"},{"key":"2316_CR17","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1093\/annonc\/mdn374","volume":"19","author":"K Amara","year":"2008","unstructured":"Amara K, Trimeche M, Ziadi S, Laatiri A, Hachana M, Korbi S: Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas. Ann Oncol. 2008, 19: 1774-1786. 10.1093\/annonc\/mdn374.","journal-title":"Ann Oncol"},{"key":"2316_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/jnci\/94.1.26","volume":"94","author":"M Esteller","year":"2002","unstructured":"Esteller M, Gaidano G, Goodman SN, Zagonel V, Capello D, Botto B, Rossi D, Gloghini A, Vitolo U, Carbone A, et al: Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma. J Natl Cancer Inst. 2002, 94: 26-32.","journal-title":"J Natl Cancer Inst"},{"key":"2316_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/304030a0","volume":"304","author":"WM Gallatin","year":"1983","unstructured":"Gallatin WM, Weissman IL, Butcher EC: A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature. 1983, 304: 30-34. 10.1038\/304030a0.","journal-title":"Nature"},{"key":"2316_CR20","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/(SICI)1097-0215(19990129)80:3<439::AID-IJC17>3.0.CO;2-V","volume":"80","author":"NS Verkaik","year":"1999","unstructured":"Verkaik NS, Trapman J, Romijn JC, van der Kwast TH, van Steenbrugge GJ: Down-regulation of CD44 expression in human prostatic carcinoma cell lines is correlated with DNA hypermethylation. Int J Cancer. 1999, 80: 439-443. 10.1002\/(SICI)1097-0215(19990129)80:3<439::AID-IJC17>3.0.CO;2-V.","journal-title":"Int J Cancer"},{"key":"2316_CR21","first-page":"2329","volume":"59","author":"W Lou","year":"1999","unstructured":"Lou W, Krill D, Dhir R, Becich MJ, Dong JT, Frierson HF, Isaacs WB, Isaacs JT, Gao AC: Methylation of the CD44 metastasis suppressor gene in human prostate cancer. Cancer Res. 1999, 59: 2329-2331.","journal-title":"Cancer Res"},{"key":"2316_CR22","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.canlet.2008.08.019","volume":"273","author":"J Hoebeeck","year":"2009","unstructured":"Hoebeeck J, Michels E, Pattyn F, Combaret V, Vermeulen J, Yigit N, Hoyoux C, Laureys G, De PA, Speleman F, et al: Aberrant methylation of candidate tumor suppressor genes in neuroblastoma. Cancer Lett. 2009, 273: 336-346. 10.1016\/j.canlet.2008.08.019.","journal-title":"Cancer Lett"},{"key":"2316_CR23","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1182\/blood-2009-09-238782","volume":"115","author":"XT Hu","year":"2010","unstructured":"Hu XT, Chen YW, Liang AC, Au WY, Wong KY, Wan TS, Wong ML, Shen L, Chan KK, Guo T, et al: CD44 activation in mature B-cell malignancies by a novel recurrent IGH translocation. Blood. 2010, 115: 2458-2461. 10.1182\/blood-2009-09-238782.","journal-title":"Blood"},{"key":"2316_CR24","volume-title":"Guide to Leukemia-Lymphoma Cell Lines","author":"HG Drexler","year":"2010","unstructured":"Drexler HG: Guide to Leukemia-Lymphoma Cell Lines. 2010, Braunschweig, 2","edition":"2"},{"key":"2316_CR25","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1093\/nar\/gni127","volume":"33","author":"AO Nygren","year":"2005","unstructured":"Nygren AO, Ameziane N, Duarte HM, Vijzelaar RN, Waisfisz Q, Hess CJ, Schouten JP, Errami A: Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res. 2005, 33: e128-10.1093\/nar\/gni127.","journal-title":"Nucleic Acids Res"},{"key":"2316_CR26","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1128\/MCB.11.11.5446","volume":"11","author":"E Shtivelman","year":"1991","unstructured":"Shtivelman E, Bishop JM: Expression of CD44 is repressed in neuroblastoma cells. Mol Cell Biol. 1991, 11: 5446-5453.","journal-title":"Mol Cell Biol"},{"key":"2316_CR27","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1093\/bioinformatics\/bti652","volume":"21","author":"C Bock","year":"2005","unstructured":"Bock C, Reither S, Mikeska T, Paulsen M, Walter J, Lengauer T: BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics. 2005, 21: 4067-4068. 10.1093\/bioinformatics\/bti652.","journal-title":"Bioinformatics"},{"key":"2316_CR28","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/hmg\/10.13.1413","volume":"10","author":"DJ Smiraglia","year":"2001","unstructured":"Smiraglia DJ, Rush LJ, Fruhwald MC, Dai Z, Held WA, Costello JF, Lang JC, Eng C, Li B, Wright FA, et al: Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum Mol Genet. 2001, 10: 1413-1419. 10.1093\/hmg\/10.13.1413.","journal-title":"Hum Mol Genet"},{"key":"2316_CR29","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1038\/sj.onc.1205275","volume":"21","author":"T Ueki","year":"2002","unstructured":"Ueki T, Walter KM, Skinner H, Jaffee E, Hruban RH, Goggins M: Aberrant CpG island methylation in cancer cell lines arises in the primary cancers from which they were derived. Oncogene. 2002, 21: 2114-2117. 10.1038\/sj.onc.1205275.","journal-title":"Oncogene"},{"key":"2316_CR30","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1182\/blood.V93.12.4347","volume":"93","author":"RA Katzenellenbogen","year":"1999","unstructured":"Katzenellenbogen RA, Baylin SB, Herman JG: Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood. 1999, 93: 4347-4353.","journal-title":"Blood"},{"key":"2316_CR31","first-page":"154","volume":"89","author":"D Rossi","year":"2004","unstructured":"Rossi D, Capello D, Gloghini A, Franceschetti S, Paulli M, Bhatia K, Saglio G, Vitolo U, Pileri SA, Esteller M, et al: Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia. Haematologica. 2004, 89: 154-164.","journal-title":"Haematologica"},{"key":"2316_CR32","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1158\/1078-0432.CCR-0378-3","volume":"10","author":"IH Wong","year":"2004","unstructured":"Wong IH, Chan J, Wong J, Tam PK: Ubiquitous aberrant RASSF1A promoter methylation in childhood neoplasia. Clin Cancer Res. 2004, 10: 994-1002. 10.1158\/1078-0432.CCR-0378-3.","journal-title":"Clin Cancer Res"},{"key":"2316_CR33","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/sj.onc.1207313","volume":"23","author":"PG Murray","year":"2004","unstructured":"Murray PG, Qiu GH, Fu L, Waites ER, Srivastava G, Heys D, Agathanggelou A, Latif F, Grundy RG, Mann JR, et al: Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma. Oncogene. 2004, 23: 1326-1331. 10.1038\/sj.onc.1207313.","journal-title":"Oncogene"},{"key":"2316_CR34","volume-title":"Leucocyte typing V; white cell differentiation antigens","author":"SF Schlossman","year":"1995","unstructured":"Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, et al: Leucocyte typing V; white cell differentiation antigens. 1995, New York: Oxford University Press"},{"key":"2316_CR35","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S1074-7613(00)00020-0","volume":"13","author":"AL Shaffer","year":"2000","unstructured":"Shaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt LM: BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity. 2000, 13: 199-212. 10.1016\/S1074-7613(00)00020-0.","journal-title":"Immunity"},{"key":"2316_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2008.06.006","volume":"134","author":"S Godar","year":"2008","unstructured":"Godar S, Ince TA, Bell GW, Feldser D, Donaher JL, Bergh J, Liu A, Miu K, Watnick RS, Reinhardt F, et al: Growth-inhibitory and tumor-suppressive functions of p53 depend on its repression of CD44 expression. Cell. 2008, 134: 62-73. 10.1016\/j.cell.2008.06.006.","journal-title":"Cell"},{"key":"2316_CR37","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/ncb1681","volume":"10","author":"Q Huang","year":"2008","unstructured":"Huang Q, Gumireddy K, Schrier M, le SC, Nagel R, Nair S, Egan DA, Li A, Huang G, Klein-Szanto AJ, et al: The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol. 2008, 10: 202-210. 10.1038\/ncb1681.","journal-title":"Nat Cell Biol"},{"key":"2316_CR38","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1749-6632.2000.tb06704.x","volume":"910","author":"P Herrlich","year":"2000","unstructured":"Herrlich P, Morrison H, Sleeman J, Orian-Rousseau V, Konig H, Weg-Remers S, Ponta H: CD44 acts both as a growth-and invasiveness-promoting molecule and as a tumor-suppressing cofactor. Ann N Y Acad Sci. 2000, 910: 106-118. 10.1111\/j.1749-6632.2000.tb06704.x.","journal-title":"Ann N Y Acad Sci"},{"key":"2316_CR39","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/sj.leu.2405071","volume":"22","author":"I Abecassis","year":"2008","unstructured":"Abecassis I, Maes J, Carrier JL, Hillion J, Goodhardt M, Medjber K, Wany L, Lanotte M, Karniguian A: Re-expression of DNA methylation-silenced CD44 gene in a resistant NB4 cell line: rescue of CD44-dependent cell death by cAMP. Leukemia. 2008, 22: 511-520. 10.1038\/sj.leu.2405071.","journal-title":"Leukemia"},{"key":"2316_CR40","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/0167-5699(89)90040-6","volume":"10","author":"BF Haynes","year":"1989","unstructured":"Haynes BF, Telen MJ, Hale LP, Denning SM: CD44--a molecule involved in leukocyte adherence and T-cell activation. Immunol Today. 1989, 10: 423-428. 10.1016\/0167-5699(89)90040-6.","journal-title":"Immunol Today"},{"key":"2316_CR41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/path.1711740205","volume":"174","author":"HJ Terpe","year":"1994","unstructured":"Terpe HJ, Koopmann R, Imhof BA, Gunthert U: Expression of integrins and CD44 isoforms in non-Hodgkin's lymphomas: CD44 variant isoforms are preferentially expressed in high-grade malignant lymphomas. J Pathol. 1994, 174: 89-100. 10.1002\/path.1711740205.","journal-title":"J Pathol"},{"key":"2316_CR42","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1182\/blood.V85.10.2885.bloodjournal85102885","volume":"85","author":"R Stauder","year":"1995","unstructured":"Stauder R, Eisterer W, Thaler J, Gunthert U: CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor. Blood. 1995, 85: 2885-2899.","journal-title":"Blood"},{"key":"2316_CR43","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1182\/blood.V75.3.589.589","volume":"75","author":"DM Lewinsohn","year":"1990","unstructured":"Lewinsohn DM, Nagler A, Ginzton N, Greenberg P, Butcher EC: Hematopoietic progenitor cell expression of the H-CAM (CD44) homing-associated adhesion molecule. Blood. 1990, 75: 589-595.","journal-title":"Blood"},{"key":"2316_CR44","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/S0046-8177(98)90426-9","volume":"29","author":"NS Aguilera","year":"1998","unstructured":"Aguilera NS, Chu WS, Andriko JA, Abbondanzo SL: Expression of CD44 (HCAM) in small lymphocytic and mantle cell lymphoma. Hum Pathol. 1998, 29: 1134-1139. 10.1016\/S0046-8177(98)90426-9.","journal-title":"Hum Pathol"},{"key":"2316_CR45","first-page":"215","volume":"47","author":"K Fujiwara","year":"1993","unstructured":"Fujiwara K, Yoshino T, Miyake K, Ohara N, Akagi T: Expression of a lymphocyte adhesion molecule (CD44) in malignant lymphomas: relevance to primary site, histological subtype and clinical stage. Acta Med Okayama. 1993, 47: 215-222.","journal-title":"Acta Med Okayama"},{"key":"2316_CR46","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1309\/TRW0-KXWV-QWG0-9XDF","volume":"117","author":"X Liang","year":"2002","unstructured":"Liang X, Golitz LE, Smoller BR, Meech SJ, Odom LF, Williams SA, Ryder JW: Association of expression of CD44v6 with systemic anaplastic large cell lymphoma: comparison with primary cutaneous anaplastic large cell lymphoma. Am J Clin Pathol. 2002, 117: 276-282.","journal-title":"Am J Clin Pathol"},{"key":"2316_CR47","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1136\/jcp.56.10.747","volume":"56","author":"A Tzankov","year":"2003","unstructured":"Tzankov A, Pehrs AC, Zimpfer A, Ascani S, Lugli A, Pileri S, Dirnhofer S: Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases. J Clin Pathol. 2003, 56: 747-752. 10.1136\/jcp.56.10.747.","journal-title":"J Clin Pathol"},{"key":"2316_CR48","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/sj.leu.2404608","volume":"21","author":"A Attarbaschi","year":"2007","unstructured":"Attarbaschi A, Mann G, Schumich A, Konig M, Pickl WF, Haas OA, Gadner H, Dworzak MN: CD44 deficiency is a consistent finding in childhood Burkitt's lymphoma and leukemia. Leukemia. 2007, 21: 1110-1113.","journal-title":"Leukemia"},{"key":"2316_CR49","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/(SICI)1096-9896(199812)186:4<383::AID-PATH202>3.0.CO;2-A","volume":"186","author":"C Beham-Schmid","year":"1998","unstructured":"Beham-Schmid C, Heider KH, Hoefler G, Zatloukal K: Expression of CD44 splice variant v10 in Hodgkin's disease is associated with aggressive behaviour and high risk of relapse. J Pathol. 1998, 186: 383-389. 10.1002\/(SICI)1096-9896(199812)186:4<383::AID-PATH202>3.0.CO;2-A.","journal-title":"J Pathol"},{"key":"2316_CR50","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/sj.leu.2401830","volume":"14","author":"LJ Bendall","year":"2000","unstructured":"Bendall LJ, Bradstock KF, Gottlieb DJ: Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells. Leukemia. 2000, 14: 1239-1246. 10.1038\/sj.leu.2401830.","journal-title":"Leukemia"},{"key":"2316_CR51","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1080\/10408360290795574","volume":"39","author":"D Naor","year":"2002","unstructured":"Naor D, Nedvetzki S, Golan I, Melnik L, Faitelson Y: CD44 in cancer. Crit Rev Clin Lab Sci. 2002, 39: 527-579. 10.1080\/10408360290795574.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2316_CR52","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1182\/blood.V99.1.290","volume":"99","author":"RS Charrad","year":"2002","unstructured":"Charrad RS, Gadhoum Z, Qi J, Glachant A, Allouche M, Jasmin C, Chomienne C, Smadja-Joffe F: Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines. Blood. 2002, 99: 290-299. 10.1182\/blood.V99.1.290.","journal-title":"Blood"},{"key":"2316_CR53","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1038\/sj.leu.2403944","volume":"19","author":"E Maquarre","year":"2005","unstructured":"Maquarre E, Artus C, Gadhoum Z, Jasmin C, Smadja-Joffe F, Robert-Lezenes J: CD44 ligation induces apoptosis via caspase-and serine protease-dependent pathways in acute promyelocytic leukemia cells. Leukemia. 2005, 19: 2296-2303. 10.1038\/sj.leu.2403944.","journal-title":"Leukemia"},{"key":"2316_CR54","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1021\/mp800024g","volume":"5","author":"VM Platt","year":"2008","unstructured":"Platt VM, Szoka FC: Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor. Mol Pharm. 2008, 5: 474-486. 10.1021\/mp800024g.","journal-title":"Mol Pharm"},{"key":"2316_CR55","first-page":"496","volume":"130","author":"LJ Picker","year":"1988","unstructured":"Picker LJ, Medeiros LJ, Weiss LM, Warnke RA, Butcher EC: Expression of lymphocyte homing receptor antigen in non-Hodgkin's lymphoma. Am J Pathol. 1988, 130: 496-504.","journal-title":"Am J Pathol"},{"key":"2316_CR56","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1182\/blood.V73.4.885.885","volume":"73","author":"ST Pals","year":"1989","unstructured":"Pals ST, Horst E, Ossekoppele GJ, Figdor CG, Scheper RJ, Meijer CJ: Expression of lymphocyte homing receptor as a mechanism of dissemination in non-Hodgkin's lymphoma. Blood. 1989, 73: 885-888.","journal-title":"Blood"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-517.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-10-517\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-517","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T07:28:13Z","timestamp":1591946893000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-10-517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,29]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["2316"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-10-517","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,29]]},"article-number":"517"}}